RHINOCORT

This brand name is authorized in Canada, Germany, Estonia, Spain, France, Hong Kong, Lithuania, Mexico, Netherlands, Singapore, South Africa

Active ingredients

The drug RHINOCORT contains one active pharmaceutical ingredient (API):

1 Budesonide UNII Q3OKS62Q6X - BUDESONIDE

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. Read about Budesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AD05	Budesonide	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02231923
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01888602
Country: EE	Ravimiamet	Identifier(s): 1043389
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64730
Country: FR	Base de données publique des médicaments	Identifier(s): 61741918
Country: HK	Department of Health Drug Office	Identifier(s): 46604, 46605
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003824, 1009787, 1067929, 1071735
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 270M98
Country: NL	Z-Index G-Standaard	Identifier(s): 13603299, 13754580
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 37397, 63711
Country: SG	Health Sciences Authority	Identifier(s): 07588P, 10374P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/21.5.1/0608, 32/21.5.1/0609